Both in Biotechnology
Voyager Therapeutics vs enGene Therapeutics
Over the past year VYGR returned −60.1% and ENGN returned −76.6%; their daily moves had a correlation of 0.16.
VYGR −60.1% ENGN −76.6%Growth of $1, one year, split-adjusted
| Metric | VYGR | ENGN |
|---|---|---|
| Price | $1.83 | $1.62 |
| Market cap | $112.8M | $108.6M |
| Today | +2.81% | +11.72% |
| 1 month | −25.6% | −13.4% |
| 6 months | −53.1% | −79.5% |
| Year to date | −53.4% | −82.1% |
| 1 year | −60.8% | −77.5% |
| Revenue growth (YoY) | −39.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −773.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $116.3M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 57.4% |
| Short % of float | 7.8% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).